Drug recall · August 28, 2024
Timolol Maleate Ophthalmic Solution USP recall
Why: Defective Container: patients are unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Timolol Maleate Ophthalmic Solution USP, 0.5%, packaged in: a) 5mL bottle (NDC 64980-514-05), and b) 10mL bottle (NDC 64980-514-01), Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey
- Lots / codes
Lot #: a) 083K063, Exp 10/31/2025; b) 083I091, Exp 08/31/2025.
- Quantity
- 176,784 bottles
- Company
- FDC Limited, Aurangabad, Maharashtra State
- Distribution
- Nationwide U.S.A.
- Initiated
- August 12, 2024 · Voluntary: Firm initiated
- Classified
- August 22, 2024
- Reported
- August 28, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Timolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.